Gene therapy involves the delivery of complex treatments to patients. In recent years, there have...
This whitepaper provides a review of global clinical trials with a start date between 1 January and 31 December 2018. Data for this review was derived from the Clinical Trials Database of GlobalData’s Pharma Intelligence Center.
The aim of this paper is to provide analyses of the main features of these trials, coupled with quarterly trends where relevant.
The clinical trials data used for these analyses were extracted from the Clinical Trials Database of GlobalData’s Pharma Intelligence Center. The data included global interventional (94%) and observational (6%) clinical trials with a start date between 1 January 2018 and 31 December 2018.
Data was analysed and segmented by sponsor type, trial phase, single or multinational trials, country, therapy area, major indication, status, major sponsors involved, and top drugs. In this report, a small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, Phase II, Phase III, and Phase IV trials respectively.